Evidence map›Paper›PMID 29492708›Full record

ArticleSurgical endoscopy2018

Does coagulopathy, anticoagulant or antithrombotic therapy matter in incisional hernia repair? Data from the Herniamed Registry.

Ralph F Staerkle, Henry Hoffmann, Ferdinand Köckerling, Daniela Adolf, Reinhard Bittner, Philipp Kirchhoff

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Surgical endoscopy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Mapping the therapeutic landscape in emergency incisional hernia: a scoping review.Hernia : the journal of hernias and abdominal wall surgery · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The reality of general surgery training and increased complexity of abdominal wall hernia surgery.Hernia : the journal of hernias and abdominal wall surgery · 2019
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Ralph F StaerkleDepartment of Surgery, Clinic for Visceral Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland. ralph.staerkle@usb.ch.
Henry HoffmannDepartment of Surgery, Clinic for Visceral Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Ferdinand KöckerlingDepartment of Surgery and Center for Minimally Invasive Surgery, Academic Teaching Hospital of Charité Medical School, Vivantes Hospital, Neue Bergstrasse 6, 13585, Berlin, Germany.
Daniela AdolfStatConsult GmbH, Halberstädter Straße 40 a, 39112, Magdeburg, Germany.
Reinhard BittnerWinghofer Medicum Hernia Center, Winghofer Strasse 42, 72108, Rottenburg am Neckar, Germany.
Philipp KirchhoffDepartment of Surgery, Clinic for Visceral Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
University Hospital of Basel · CHCharité - Universitätsmedizin Berlin · DEInfoConsult (Germany) · DEWinghofer Medicum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA considerable number of patients undergoing incisional hernia repair are on anticoagulant or antiplatelet therapy or have existing coagulopathy which may put them at higher risk for postoperative bleeding complications. Data about the optimal treatment of these patients are sparse. This analysis attempts to determine the rate of postoperative bleeding complications following incisional hernia repair and the consecutive rate of reoperation among patients with coagulopathy or receiving antiplatelet and anticoagulant therapy (higher risk group) compared to patients who do not have a higher risk (normal risk group).

methodsOut of the 43,101 patients documented in the Herniamed Registry who had an incisional hernia repair, 6668 (15.5%) were on anticoagulant or antithrombotic therapy or had existing coagulopathy. The implication of that higher risk profile for onset of postoperative bleeding was investigated in multivariable analysis. Hence, other influential variables were identified.

resultsThe rate of postoperative bleeding in the higher risk group was 3.9% (n = 261) and significantly higher compared to the normal risk group at 1.6% (n = 564) (OR 2.001 [1.699; 2.356]; p < 0.001). Additionally, male gender, use of drains, larger defect size, open incisional hernia repair, lower BMI, and higher ASA score significantly increased the risk of postoperative bleeding. The rate of reoperations due to postoperative bleeding was significantly increased in the higher risk group compared to the normal risk group (2.4 vs. 1.0%; OR 1.217 [1.071; 1.382]; p = 0.003). Likewise, the postoperative general complication rate (6.04 vs. 3.66%; p < 0.001) as well as the mortality rate (0.46 vs. 0.17%; p < 0.001) were significantly higher in the higher risk group.

conclusionsPatients with anticoagulant or antiplatelet therapy or existing coagulopathy who undergo incisional hernia repair have a significantly higher risk for onset of postoperative bleeding. The risk of bleeding complications and complication-related reoperations seems to be lower after laparoscopic intraperitoneal onlay mesh.

Indexed as

AgedAnticoagulantsBlood Coagulation DisordersFemaleFibrinolytic AgentsGermanyHerniorrhaphyHumansIncidenceIncisional HerniaLaparoscopyMaleMiddle AgedPostoperative HemorrhageRegistriesReoperationAnticoagulantsFibrinolytic AgentsAnticoagulant therapyAntithrombotic therapyBleedingCoagulopathyIncisional herniaPostoperative complication

Identifiers

PMID29492708
PMCPMC6096530
OpenAlexW2793933756

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.